Effect of metformin on prostate cancer outcomes after radical prostatectomy - Wikidata - wikimedia - TriplyDB

Effect of metformin on prostate cancer outcomes after radical prostatectomy

Effect of metformin on prostate cancer outcomes after radical prostatectomy

http://www.wikidata.org/entity/Q33551333

about

Obesity and cancer: mechanistic insights from transdisciplinary studies Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies Nutrition, dietary interventions and prostate cancer: the latest evidence Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Metformin effects on biochemical recurrence and metabolic signaling in the prostate.Effects of metformin on retinoblastoma growth in vitro and in vivo.Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation.Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort.A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy.The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia.Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.

P2860

Q26786829-0389A67D-E28F-456A-B3C6-FE32F86899B2 Q28074225-7A4A6D4E-8FD3-4A22-801C-15A020B7F84D Q28081491-A0286348-7A1E-4BF8-BD23-D29A9D3C1218 Q28084566-447881BA-D5D0-43CB-849A-FDED708B4A52 Q28542914-5CDFFE71-7B04-4B11-9DCF-1DBA5E5A7904 Q30665188-771D160B-2FD4-48A3-B07F-B051CD1A68D9 Q34432841-8EE803A8-BAB9-4512-9A5E-C62580908B5E Q35149589-463FD1B9-D1DA-4BC5-B78B-125702DDD457 Q35290403-8F07D893-2503-4BBD-BEE7-F9C043AA8A2A Q35558619-8B4EB03E-0ECF-4AEB-8B59-F22C296237A4 Q37315465-6F7BC9C9-D992-448F-99B1-1FD200A4AD28 Q37404368-924995B3-2873-409D-8BB7-5E8BC036FE16 Q37690270-6BE7A242-7ECB-4879-A6EA-576ED544A94F Q38226775-0372E25A-791F-449A-B6AF-B94F1E258DF6 Q38660247-645CB46A-D02E-494A-9102-F3878152854A Q39124486-E702DE5F-122D-418E-944E-9D7D4DF287F7 Q41963534-44E5B801-9C0C-4A29-8BE8-EC6A2DAF32F9 Q41964435-A2E2DE68-E8FD-4783-B91E-EDC59B631A9D Q47116201-3E03AD95-1A06-45A0-90DE-8452F0F25E2C Q50050991-B3AA1025-EE0F-4896-A848-B3509297600B Q53166209-28FB895E-72E0-4963-BD56-DD247A6A6607

P2860

Effect of metformin on prostate cancer outcomes after radical prostatectomy

http://www.wikidata.org/entity/Q33551333

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@ast

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@en

Effect of metformin on prostate cancer outcomes after radical prostatectomy.

@nl

type

label

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@ast

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@en

Effect of metformin on prostate cancer outcomes after radical prostatectomy.

@nl

prefLabel

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@ast

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@en

Effect of metformin on prostate cancer outcomes after radical prostatectomy.

@nl

P1433

Q33551333-6DF620FB-DEB4-40C4-9B19-7F802237B25C

P1476

Q33551333-2569FF9C-2892-41DC-8A36-202F5808B45E

P2093

Q33551333-2F2B7B8D-C80C-4435-A68D-522A5B03828E

Q33551333-4FB8851E-E8C1-4D67-B02D-AB0CBBCFACB1

Q33551333-8203CCA3-079D-4011-9A65-CDA938B34BDB

Q33551333-AFF26A55-BBCA-4320-96B3-87057883149A

Q33551333-FF74776C-0919-42FB-B4E6-98DB0E284474

P2860

Q33551333-02B5B1F5-B833-430D-AA6B-FE982DE1B320

Q33551333-14620D45-57CE-490C-A616-DB305C90CEFA

Q33551333-16652E78-3233-40D9-8EB0-86332D703BA2

Q33551333-1F904EFE-BFAC-4F4D-B16C-ABD60AA76DED

Q33551333-331A1BD5-3524-4898-A180-5579EE00D63C

Q33551333-3A4BA195-019A-4340-AA3F-F8B22ED6F056

Q33551333-3C731B75-926D-49C1-88F0-7BFA906DCE80

Q33551333-44F3002F-80AA-42D4-8785-6CB9A94ED024

Q33551333-530C0E07-D169-44D3-A624-A911B1AD0E00

Q33551333-652830FB-9DB8-4190-8E6B-D9DDC444CE22

P304

Q33551333-87CF2A11-A9EC-4F1C-B095-F9307C7406E8

P31

Q33551333-7D86997D-C6BA-4D31-A924-A2AFBBCFC151

P356

Q33551333-E69DFA3F-F6F5-43F2-9EA1-816F3AA365C5

P433

Q33551333-098E1AD9-08D8-4FB2-8947-A1E032EBAD46

P478

Q33551333-1F2B2893-A618-4B41-A592-671BF2AFF5CF

P50

Q33551333-A2EF8B33-3FC9-4058-98F0-B32B2CD470DC

P577

Q33551333-EA84591B-5DFE-40A8-99FB-B51445A09DFE

P698

Q33551333-36F1C29D-DBCB-4DE6-9790-5B2981A6DCF7

P921

Q33551333-D05702BF-78B0-448E-8549-F8FE5040A80F

P932

Q33551333-231CD396-6F58-4184-8E4E-03C6CDA7125A

P356

J.UROLONC.2013.05.005

P1433

Urologic Oncology

P1476

Effect of metformin on prostate cancer outcomes after radical prostatectomy

@en

P2093

Eric J Bergstralh

http://www.w3.org/2001/XMLSchema#string

Laureano J Rangel

http://www.w3.org/2001/XMLSchema#string

Manuel S Eisenberg

http://www.w3.org/2001/XMLSchema#string

R Jeffrey Karnes

http://www.w3.org/2001/XMLSchema#string

Rachel E Carlson

http://www.w3.org/2001/XMLSchema#string

P2860

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Metformin and reduced risk of cancer in diabetic patients

Time-dependent bias was common in survival analyses published in leading clinical journals.

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.

LKB1-dependent signaling pathways.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

P304

43.e1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2013.05.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23810664

http://www.w3.org/2001/XMLSchema#string

P921

P932

4006350

http://www.w3.org/2001/XMLSchema#string